方法：以我院眼科收治2型糖尿病白内障患者103例112眼为观察对象，并以同期无糖尿病单纯白内障老年患者100例110眼为对照，同一组医务人员进行超声乳化吸除术联合人工晶状体植入术，比较两组近期视力、远期视力及并发症。

结果：观察组术后1d； 1wk，患者视力较术前均有明显好转(Z=7.63，8.59，P<0.05)，对照组术后1d； 1wk，患者视力较术前均有明显好转(Z=5.36，4.38，P<0.05)； 观察组在术后1d； 1wk视力较对照组有明显好转(Z=5.48，4.68，P<0.05)，观察组最佳矫正视力低于对照组，差异有统计学意义(Z =8.987，P<0.05)； 观察组在术后1，3mo视力均低于对照组，差异有统计学意义(Z=13.21，11.48，P<0.05)。术后6mo，两组差异无统计学意义(Z=3.141，P>0.05)

结论：2型糖尿病白内障患者在血糖控制良好条件下行超声乳化联合人工晶状体植入术能明显改善患者视力，并未发现明显并发症，疗效可靠。

METHODS: Atotal of 103 cases(112 eyes)Ⅱ diabetes patients with cataract treated in our hospital were as observation object, and 100 cases(110 eyes)of elderly patients with pure without diabetes cataract were for comparison, with the same set for medical ultrasound emulsification gettering technique combined IOL implantation, two groups in the near future vision, long-term vision and complications were compared.

RESULTS: Vision in the observation group patients after 1d, 1 week and preoperative had obviously improved(Z=7.63, 8.59, P<0.05), Vision in the control group patients after 1d, 1 week and preoperative had obviously improved(Z=5.36, 4.38, P<0.05); observation group after 1d, 1 week vision had obviously improved compared with the control group(Z=5.48, 4.68, P<0.05), best corrected visual acuity in observation group was better than the control group, the difference was statistically significant(Z=8.987, P<0.05); observation group after 1 month, 3 months visual acuity were lower than the control group, the difference were statistically significant(Z=13.21, 11.48, P<0.05), and there was no significant difference between the two groups 6 months postoperatively(Z=3.141,P>0.05).

CONCLUSION: Using ultrasonic emulsification combined IOL implantation for Ⅱ diabetes patients with cataract in good glycemic control can significantly improve patients visual acuity and found no obvious complications, curative effect is reliable.